Duane L. Sherrill

Duane L. Sherrill

Auto-generated profile, based on publicly available information

Duane L. Sherrill

Mel and Enid Zuckerman College of Public Health, University of Arizona, Arizona, USA

Research Focus & Metrics

Academic Career Length

29Years (1998-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2004 in Chest
Verified
Journal Article
Closed access
PDF file
GSGraciela E. Silva
Graciela E. Silva
DSDuane L. Sherrill
Duane L. Sherrill
SGStefano Guerra
Stefano Guerra
RBRobert A. Barbee
Robert A. Barbee

28 September 1998 in Archives of internal medicine (1960)
Verified
Journal Article
Open access
PDF file
DSDuane L. Sherrill
Duane L. Sherrill
KKKimberly Kotchou
Kimberly Kotchou
SQStuart F. Quan
Stuart F. Quan
SYMPTOMS OF disturbed sleep are common in the general population, with overall prevalence rates of between 35% and 41%.1-3 This is especially true in the elderly, in whom up to 50% of those surveyed may express some dissatisfaction with the quality of their sleep.2,3 Factors contributing to poor sleep include concomitant medical problems, psychiatric and/or psychological conditions, and poor sleep hygiene.4-6 Furthermore, sleep disturbances are frequently chronic, with 56% of those affected continuing to have symptoms for years.4

1 December 1999 in American Journal of Respiratory and Critical Care Medicine
Verified
Journal Article
Closed access
DSDuane L. Sherrill
Duane L. Sherrill
PEPaul L. Enright
Paul L. Enright
WKWalter T. Kaltenborn
Walter T. Kaltenborn
MLMichael D. Lebowitz
Michael D. Lebowitz
Low single-breath diffusing capacity (DlCO) values are associated with anatomic emphysema, but the predictors of longitudinal change in DlCO over many years are unknown. Study subjects were adult participants in the longitudinal Tucson Epidemiology Study of Obstructive Lung Disease who had at least one DlCO measurement during either of two surveys 8 yr apart (n = 543). Smoking status was determined at each examination (current, former, or never smoker). Quitters were defined as those currently smoking at the baseline DlCO examination (1982–1983) and self-reported as no longer smoking at the follow-up exam (1990–1991). The longitudinal DlCO data were analyzed using repeated measures analysis; because of missing observations this was done using a saturated random effects model. The results showed that males had higher levels of DlCO than females, current smokers had significantly lower levels of DlCO than never smokers, but there was no difference in their mean slopes over time. Smoking history, assessed using pack-years of smoking, was associated with reduced DlCO levels, independent of whether current or ex-smokers. Males and females demonstrated equivalent rates of decline in DlCO that accelerated with increasing age, and mean DlCO declines were associated with declines in FEV1 between surveys. Sherrill DL, Enright PL, Kaltenborn WT, Lebowitz MD. Predictors of longitudinal change in diffusing capacity over 8 years.

1 May 2003 in Chest
Verified
Journal Article
Closed access
PDF file
GSGraciela E. Silva
Graciela E. Silva
DSDuane L. Sherrill
Duane L. Sherrill
SGStefano Guerra
Stefano Guerra
RBRobert A. Barbee
Robert A. Barbee

1 November 2005 in Respiratory Medicine
Verified
Journal Article
Closed access
DSDuane L. Sherrill
Duane L. Sherrill
SGStefano Guerra
Stefano Guerra
MMM. Cristina Minervini
M. Cristina Minervini
AWAnne L. Wright
Anne L. Wright
FMFernando D. Martinez
Fernando D. Martinez

1 January 2003 in European Respiratory Journal
Verified
Journal Article
Closed access
PDF file
DSD. Sherrill
D. Sherrill
SGS. Guerra
S. Guerra
ABA. Bobadilla
A. Bobadilla
RBR. Barbee
R. Barbee
Several recent reports have presented evidence suggesting that adults with asthma have an accelerated rate of decline in pulmonary function compared with nonasthmatics. However, most of these studies have not taken into account the possible effect of comorbid lung disease in addition to asthma. This study was designed to determine if comorbid respiratory diseases modify or otherwise change the estimates of decline in forced expiratory volume in one second (FEV1).Study subjects were White, non-Mexican, American participants, who were ≥20 yrs of age at the initial survey and had at least one pulmonary function testing. Respiratory disease status, based on self-reported questionnaires and pulmonary function tests, were assessed during 12 surveys spanning a period of up to 20 yrs.There were 2,926 subjects who met the inclusion criteria, 214 (7.3%) had physician-confirmed asthma, 325 (11.1%) chronic obstructive pulmonary disease (COPD), and 125 (4.3%) both physician-confirmed asthma and COPD. Longitudinal analysis revealed that among those with longstanding asthma, FEV1values were low but did not decline at a more rapid rate than normal. Likewise, subjects with both asthma and COPD had the lowest levels of FEV1, but also a rate of decline that was not significantly increased. Only those with COPD in the absence of asthma experienced both a low initial FEV1level and a significantly steeper rate of decline.Based on these findings, the authors conclude that forced expiratory volume in one second does not decline more rapidly in asthmatics or in those with asthma and chronic obstructive pulmonary disease, compared with nonasthmatics.